Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma
Clinical trial NCT00587288 · COMPLETED
Trial details
- NCT number
- NCT00587288
- Sponsor
- Ception Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2010-03-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.